Cellromax Science Co., Ltd. (KOSDAQ:471820)
5,060.00
-70.00 (-1.36%)
At close: Mar 6, 2026
Cellromax Science Market Cap
Cellromax Science has a market cap or net worth of 54.78 billion as of March 9, 2026. Its market cap has decreased by -13.99% in one year.
Market Cap
54.78B
Enterprise Value
49.58B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5,060.00
Market Cap Chart
Since December 13, 2024, Cellromax Science's market cap has decreased from 92.69B to 54.78B, a decrease of -40.89%. That is a compound annual growth rate of -34.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 54.78B | -24.31% |
| Dec 30, 2025 | 72.38B | 26.47% |
| Dec 30, 2024 | 57.23B | -38.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JNB Co., Ltd. | 52.70B |
| Laseroptek | 61.70B |
| Korea No.14 Special Purpose Acquisition | 50.53B |
| Mirae Asset Vision Special Purpose Acquisition 2 Company | 43.80B |
| ALT Co., Ltd. | 77.35B |
| Shinhan 11th Special Purpose Acquisition Company | 39.61B |
| GITSN | 80.32B |
| Black Yak I&C Co.,Ltd | 82.41B |